Previously, we unveiled LKB1’s influence on the Wnt/β-catenin pathway in lung cancer, along with indications that silencing LKB1 leads to heightened epithelial–mesenchymal transition (EMT) markers [21]. Here, STK11 is linked to lung cancer.